Class 2 Medicines : Norgine Pharmaceuticals Limited, Pedmarqsi 80
OFFICIAL-SOURCE RECALL · UNITED KINGDOM
Class 4 Medicines Defect Notification: Brancaster Pharma Limited Recall: Brancaster Pharma Limited has
Use the identifiers printed on your item to determine whether this recall may affect the product you own.
CountryUnited KingdomPublishedJune 29, 2026Last updatedJune 29, 2026Official source last checkedSeptember 9, 2026 at 1:48 PM UTC
CHECK THE ITEM YOU OWN
Is your product affected?
- Brand
- See official notice
- Product
- Class 4 Medicines Defect Notification: Brancaster Pharma Limited, Benzylpenicillin benzathine 1.2 Million I.U. and 2.4 Million I.U. powder for suspension for injection, EL(26)A/30
- Manufacturer
- See official notice
The barcode may identify the product type, while the recall may apply only to certain lots, dates or variants. Check all identifiers listed in the official recall.
Why this product was recalled
Brancaster Pharma Limited has informed the MHRA that the Patient Information Leaflet (PIL) in the cartons for the batches listed in this notification were released with an outdated PIL.
Hazard
Brancaster Pharma Limited has informed the MHRA that the Patient Information Leaflet (PIL) in the cartons for the batches listed in this notification were released with an outdated PIL.
What consumers should do
for Healthcare Professionals: Healthcare professionals should read the details in this notification and take this into account when reconstituting and administering these products. Upon request, Brancaster Pharma Limited will provide hard copies of the updated PIL to wholesalers and pharmacies so that any packs can be supplemented with the correct PIL information. To request hard copies of the PIL, please contact enquiries@brancasterpharma.com with your details, i.e. address, product with batch details, required number of leaflets. The correct PIL is available: Click here The information in the updated PIL reflects the current section 6.6 of the SmPC: Click here Advice for Patients: The quality of the powder for suspension for injection is not affected by this issue. The information missing from the Patient Information Leaflet (PIL) relates only to updated instructions for healthcare professionals on the preparation and administration of the injection. These products are prepared and administered by healthcare professionals and the missing information has been provided to them when preparing the medication. No further action is required for the patient. Patients who experience adve
Official recall notice
Class 4 Medicines Defect Notification: Brancaster Pharma Limited, Benzylpenicillin benzathine 1.2 Million I.U. and 2.4 Million I.U. powder for suspension for injection, EL(26)A/30
Agency: Medicines and Healthcare products Regulatory Agency
Official publication date: June 29, 2026
Read the official UK_MHRA recall notice →SCAN ONCE. KEEP WATCHING.
Keep an eye on the products at home.
Scan food and household product barcodes, save your items and get notified when a future recall may match.
